- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-02-0007828

About Eliscription Private Limited
Data last updated:
Eliscription Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Elico Ltd. It operates in the medical transcription segment of the business process outsourcing sector. It was incorporated on 26 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2013PTC086622. Its GSTIN is 36AADCE3440N1ZJ (Telangana). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vanitha Datla and Ramesh Datla.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 91 Apie Sanathnagar Industrialestate Extension, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.9 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹57.37 Lakh (net margin -7.3%) and EBITDA of ₹32.86 Lakh (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Eliscription. As per MCA filings, the company has open charges of ₹6.43 Cr and satisfied charges of ₹5.31 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
Eliscription Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0007828). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eliscription.com.
Company details
CIN history
Eliscription has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74900TG2013PTC086622, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900TG2013PTC086622 | Current |
| U74900AP2013PTC086622 | Previous |
| U63119TG2013PTC086622 | Previous |
Recognitions & Rankings of Eliscription
Contact details
Eliscription Private Limited's registered office is in Hyderabad, Telangana. Its website is eliscription.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 91 Apie Sanathnagar Industrialestate Extension, Hyderabad, Telangana, India – 500018
- IndustryBusiness Outsourcing, Medical Transcription
To see the full contact details of Eliscription Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eliscription operates one associated brand: Eliscription. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides medical transcription and documentation for healthcare providers and organizations. | eliscription.com |
Business activity
The main business activity of Eliscription is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Eliscription Private Limited, buy the company report.
Financials of Eliscription Private Limited
FY 2024 filings availableEliscription Private Limited reported revenue of ₹7.9 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 3% fall in the latest year. EBITDA rose 949% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹57.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | -7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eliscription Private Limited, buy the company report.
Board of directors and KMP of Eliscription Private Limited
Eliscription Private Limited currently reports 2 directors and 1 key managerial person.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sri Kanth Kasala | Ceo | 01 Jan 2021 | 5 Years 10 Months | Current |
| Vanitha Datla Also directs: Elico Mechoptronix Private Limited, Elico Ltd, Elico Healthcare Services Limited and 3 more | Director | 26 Mar 2013 | 13 Years 7 Months | Current |
| Ramesh Datla | Director | 26 Mar 2013 | 13 Years 7 Months | Current |
Peer comparison
Eliscription Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other information & communication service activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Snet Networks Private Limited | ₹7.94 Cr (FY 2024) | -12.0% | Mumbai, Maharashtra, India | |||
| Z-Axis Tech Solutions (India) Private Limited | ₹7.93 Cr (FY 2016) | 29.0% | Hyderabad, Telangana, India | |||
| Eleserv Softech Private Limited | ₹7.92 Cr (FY 2025) | 194.0% | New Delhi, Delhi, India | |||
| Eurolandcom India Private Limited | ₹7.91 Cr (FY 2024) | 23.0% | Bangalore, Karnataka, India | |||
| Alignminds Technologies Private Limited | ₹7.9 Cr (FY 2024) | -9.0% | Tripunithura, Kerala, India | |||
| Eliscription Private Limitedthis company | ₹7.9 Cr (FY 2025) | -₹57.37 Lakh | -7.3% | -3.0% | 1 | Hyderabad, Telangana, India |
| Maxsquare Infotech Private Limited | ₹7.89 Cr (FY 2018) | 1279.0% | Kolkata, West Bengal, India | |||
| Scom Online Private Limited | ₹7.87 Cr (FY 2025) | -15.0% | Latur, Maharashtra, India | |||
| Menson(India) Private Limited | ₹7.87 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Vtest Software Private Limited | ₹7.87 Cr (FY 2025) | -29.0% | Pune, Maharashtra, India | |||
| Atvantiq Networks Private Limited | ₹7.87 Cr (FY 2025) | 71.0% | Mohali, Punjab, India |
To see the full peer comparison of Eliscription Private Limited, buy the company report.
Auditor
Eliscription Private Limited is audited by akasam & associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| akasam & associates | FY 2022 | 005832S |
Shareholding
The shareholding of Eliscription Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eliscription Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2022 | 100561560 | Others | ₹1.43 Cr | Open | |
| 31 Mar 2021 | 100435301 | Others | ₹2.5 Cr | Open | |
| 24 Jun 2020 | 100343601 | Others | ₹2.5 Cr | Open | |
| 30 Sep 2021 | 100505725 | Axis Bank Limited | ₹55.93 Lakh | Satisfied | |
| 15 Feb 2019 | 100248970 | Axis Bank Limited | ₹64 Lakh | Satisfied |
To see the full charge records of Eliscription Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Eliscription Private Limited has 2 court cases on record: 1 filed by Eliscription, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Regional Provident Fund Commissioner-I | Disposed |
| District court, MYSURU, Karnataka | Court case (Ref) | Filed against the company by an individual | Disposed |
To see the full case history of Eliscription Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eliscription Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eliscription Private Limited has a workforce of 1 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 1 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Eliscription Private Limited, buy the company report.
GST
Eliscription has 5 GST registrations: 3 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCE3440N1ZJ | Telangana | Active | 01 Jul 2017 |
| 29AADCE3440N1DN | Karnataka | Active | 05 Dec 2019 |
| 29AADCE3440N2ZD | Karnataka | Active | 23 Dec 2021 |
To see the full GST registrations and return filing status of Eliscription Private Limited, buy the company report.
Recent activity
Eliscription Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Sri Kanth Kasala was appointed as CEO on 01 Jan 2021.
9 earlier events are in the company report.
Frequently asked questions
Eliscription is an active private limited company based in Hyderabad, Telangana, India. The company works in medical transcription, within the business outsourcing industry. It was incorporated on 26 March 2013 (13+ years old) and is registered under CIN U74900TG2013PTC086622.
Eliscription has 3 current directors and KMP:
- Vanitha Datla - Director
- Ramesh Datla - Director
- Sri Kanth Kasala - Ceo
The latest financial statements of Eliscription on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Eliscription is 36AADCE3440N1ZJ, registered in Telangana. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 29AADCE3440N1DN (Karnataka), 29AADCE3440N2ZD (Karnataka).
The CIN (Corporate Identification Number) of Eliscription is U74900TG2013PTC086622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eliscription has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Eliscription was incorporated on 26 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Eliscription by revenue are Snet Networks Private Limited, Z-Axis Tech Solutions (India) Private Limited, Eleserv Softech Private Limited, Eurolandcom India Private Limited, Alignminds Technologies Private Limited and 5 more, all in the same principal business activity (other information & communication service activities).
Sri Kanth Kasala was appointed as CEO on 01 Jan 2021. Ramesh Datla was appointed as Director on 26 Mar 2013. Vanitha Datla was appointed as Director on 26 Mar 2013.
Yes, Eliscription is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0007828).
Eliscription can be reached through the website eliscription.com. Its registered office is in Hyderabad, Telangana, India.

